DARIOHEALTH CORP (DRIO) Stock Analyst Ratings
NASDAQ:DRIO - Nasdaq - US23725P2092 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to DRIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.68. This target is 288.04% above the current price.
DRIO was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about DRIO.
In the previous month the buy percentage consensus was at a similar level.
DRIO was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-19 | Litchfield Hills | Initiate | Buy |
| 2025-03-11 | Stifel | Maintains | Buy -> Buy |
| 2024-04-01 | Stifel | Maintains | Buy -> Buy |
| 2023-08-11 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2023-07-25 | Stifel | Maintains | Buy -> Buy |
| 2023-05-12 | Craig-Hallum | Maintains | Buy -> Buy |
| 2022-11-16 | Alliance Global Partners | Maintains | Buy |
| 2022-08-18 | Aegis Capital | Maintains | Buy |
| 2022-08-16 | Cowen & Co. | Maintains | Outperform |
| 2022-05-16 | Aegis Capital | Maintains | Buy |
| 2022-05-16 | Cowen & Co. | Maintains | Outperform |
| 2022-05-13 | Alliance Global Partners | Upgrade | Neutral -> Buy |
| 2022-01-26 | Aegis Capital | Maintains | Buy |
| 2021-08-19 | Aegis Capital | Maintains | Buy |
| 2021-04-22 | Cowen & Co. | Initiate | Outperform |
| 2021-03-23 | Stifel | Initiate | Buy |
| 2021-02-08 | Aegis Capital | Maintains | Buy |